Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00169156
Status:
COMPLETED
Last Update Posted:
2017-03-13
First Post:
2005-09-12
Brief Title:
A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma
Sponsor:
Lymphoma Study Association
Organization:
Lymphoma Study Association
Study Overview
Official Title:
Study of the Efficacy and the Safety of First Line Treatment With CHOP Plus Rituximab R-CHOP in Patients Aged 60 to 80 Years With Previously Untreated T-cell Angioimmunoblastic Lymphoma AIL
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the efficacy and the safety of a front-line treatment combining CHOP regimen and rituximab in patients aged 60 to 80 years with previously untreated AIL
Detailed Description:
This is a multicentric open-label non-randomized clinical study evaluating the efficacy and the safety of a front-line treatment combining CHOP regimen and rituximab in patients aged 60 to 80 years with previously untreated AIL
It is anticipated that 25 subjects will be enrolled over 2 years from 2005 2007Analysis performed every 5 patients based on triangular test
The duration of the treatment period is approximately 25 weeks and patients are followed until Death
The total Duration of the study is expected to be 25 years
It is anticipated that 25 subjects will be enrolled over 2 years from 2005 2007Analysis performed every 5 patients based on triangular test
The duration of the treatment period is approximately 25 weeks and patients are followed until Death
The total Duration of the study is expected to be 25 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-002602-37 | EUDRACT_NUMBER | None | None |